<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01784926</url>
  </required_header>
  <id_info>
    <org_study_id>2012/1981</org_study_id>
    <nct_id>NCT01784926</nct_id>
  </id_info>
  <brief_title>Late Dislocation of Intraocular Lens (IOL) Following Cataract Surgery: an Evaluation of Two Different Surgical Methods</brief_title>
  <official_title>Late Dislocation of Intraocular Lens (IOL) Following Cataract Surgery: an Evaluation of Two Different Surgical Methods</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Oslo University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Oslo University Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      A prospective randomized study on patients with late in the bag intraocular lens (IOL)
      dislocation, after cataract surgery. To obtain normal visual function, these patients needs
      surgery. In this study the investigators will look for advantages and dis-advantages after
      two different surgical approaches to late in-the-bag IOL dislocation.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      In this prospective, randomized study The investigators will include at least 80 patients
      with late intraocular lens (IOL) dislocation in the capsular complex, after cataract surgery.
      To obtain normal visual function, these patients needs surgery. Today, there are two
      different methods used for this condition; scleral suturing of the capsular complex or
      exchange of IOL to an iris-fixated IOL (Verisyse). In this study the investigators will look
      for advantages and dis-advantages for these two methods.
    </textblock>
  </detailed_description>
  <overall_status>Active, not recruiting</overall_status>
  <start_date>January 2013</start_date>
  <completion_date type="Anticipated">December 2020</completion_date>
  <primary_completion_date type="Actual">June 2016</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
    <masking_description>Investigator masked for group affiliation during image analysis</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>Best Corrected Visual Acuity (BCVA)</measure>
    <time_frame>6 months, 1 year and 2 years</time_frame>
    <description>Measure for visual function. Measured in logMAR</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Intraocular Pressure (IOP)</measure>
    <time_frame>6 months and 2 years</time_frame>
    <description>Measure for the pressure inside the eye, measured with Goldman applanation tonometer, in mmHg.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Endothelial Density</measure>
    <time_frame>6 months</time_frame>
    <description>Corneal endothelial cell density (ECD), measured by confocal microscopy. Reported in cells per square millimeter</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Postoperative Complications</measure>
    <time_frame>6 months and 2 years</time_frame>
    <description>Cystoid macular edema considered the most important long-term complication and therefore reported here.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Keratometry</measure>
    <time_frame>6 months (only analyzed/reported for this time frame)</time_frame>
    <description>Keratometry of the cornea. Corneal astigmatism, measured in diopters.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Questionnaire Visual Function-14 (VF-14) Score</measure>
    <time_frame>6 months (only analyzed/reported for this time frame)</time_frame>
    <description>Questionnaire considering subjective visual function, scale 0-100 (higher scores mean better subjective visual outcome, lower scores means worse outcome).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>IOL Location</measure>
    <time_frame>2 years</time_frame>
    <description>Measure IOL's location with slit lamp and Pentacam.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">104</enrollment>
  <condition>Intraocular Lens Dislocation</condition>
  <arm_group>
    <arm_group_label>IOL repositioning</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Operation method: Intraocular lens repositioning by scleral suturing</description>
  </arm_group>
  <arm_group>
    <arm_group_label>IOL exchange</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Operation method: Intraocular lens exchange with retropupillary iris-claw lens</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Intraocular lens repositioning by scleral suturing</intervention_name>
    <arm_group_label>IOL repositioning</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Intraocular lens exchange with retropupillary iris-claw lens</intervention_name>
    <arm_group_label>IOL exchange</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  patients with dislocation of IOL in the capsular complex who agree to participate in
             the study

        Exclusion Criteria:

          -  patients with total dislocation of the capsular complex'

          -  patients with reduced general health

          -  patients who can't be randomized
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Liv Drolsum, MD, PhD</last_name>
    <role>Study Chair</role>
    <affiliation>Oslo University Hospital</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Oslo University Hospital</name>
      <address>
        <city>Oslo</city>
        <country>Norway</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Norway</country>
  </location_countries>
  <verification_date>September 2019</verification_date>
  <study_first_submitted>January 29, 2013</study_first_submitted>
  <study_first_submitted_qc>February 5, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 6, 2013</study_first_posted>
  <results_first_submitted>April 19, 2017</results_first_submitted>
  <results_first_submitted_qc>September 2, 2019</results_first_submitted_qc>
  <results_first_posted type="Actual">September 27, 2019</results_first_posted>
  <last_update_submitted>September 2, 2019</last_update_submitted>
  <last_update_submitted_qc>September 2, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">September 27, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Oslo University Hospital</investigator_affiliation>
    <investigator_full_name>Marius Dalby</investigator_full_name>
    <investigator_title>MSc</investigator_title>
  </responsible_party>
  <keyword>cataract surgery</keyword>
  <keyword>scleral suturing</keyword>
  <keyword>Verisyse</keyword>
  <keyword>Late in-the-bag IOL dislocation</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Joint Dislocations</mesh_term>
    <mesh_term>Cataract</mesh_term>
    <mesh_term>Lens Subluxation</mesh_term>
  </condition_browse>

  <clinical_results>

    <participant_flow>
      <recruitment_details>Altogether 175 patients were assessed for eligibility, 104 patients were enrolled.</recruitment_details>
      <group_list>
        <group group_id="P1">
          <title>IOL Repositioning</title>
          <description>Operation method: Intraocular lens repositioning by scleral suturing
54 patients were randomised to this group. 11 patients were lost to follow-up before the 6-month postoperative visit because of serious illness and 1 death (unrelated to the condition studied).</description>
        </group>
        <group group_id="P2">
          <title>IOL Exchange</title>
          <description>Operation method: Intraocular lens exchange with retropupillary iris-claw lens
50 patients were randomised to this group. 8 patients were lost to follow-up before the 6-month postoperative visit because of serious illness (unrelated to the condition studied).</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="54"/>
                <participants group_id="P2" count="50"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="43"/>
                <participants group_id="P2" count="42"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="11"/>
                <participants group_id="P2" count="8"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>IOL Repositioning</title>
          <description>Operation method: Intraocular lens repositioning by scleral suturing</description>
        </group>
        <group group_id="B2">
          <title>IOL Exchange</title>
          <description>Operation method: Intraocular lens exchange with retropupillary iris-claw lens</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="54"/>
            <count group_id="B2" value="50"/>
            <count group_id="B3" value="104"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Full Range</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="81" lower_limit="56" upper_limit="94"/>
                    <measurement group_id="B2" value="82" lower_limit="63" upper_limit="95"/>
                    <measurement group_id="B3" value="81.5" lower_limit="56" upper_limit="95"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="34"/>
                    <measurement group_id="B2" value="29"/>
                    <measurement group_id="B3" value="63"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="20"/>
                    <measurement group_id="B2" value="21"/>
                    <measurement group_id="B3" value="41"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Ethnicity (NIH/OMB)</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Hispanic or Latino</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Not Hispanic or Latino</title>
                  <measurement_list>
                    <measurement group_id="B1" value="54"/>
                    <measurement group_id="B2" value="50"/>
                    <measurement group_id="B3" value="104"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Unknown or Not Reported</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <title>Norway</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="54"/>
                    <measurement group_id="B2" value="50"/>
                    <measurement group_id="B3" value="104"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Mean best-corrected visual acuity</title>
          <units>logMAR</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0.37" spread="0.42"/>
                    <measurement group_id="B2" value="0.64" spread="0.77"/>
                    <measurement group_id="B3" value="0.50" spread="0.63"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Mean intraocular pressure</title>
          <units>mmHg</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="17.7" spread="5.0"/>
                    <measurement group_id="B2" value="18.3" spread="7.2"/>
                    <measurement group_id="B3" value="18.0" spread="6.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Mean time since cataract surgery</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="10.6" spread="4.3"/>
                    <measurement group_id="B2" value="10.0" spread="4.3"/>
                    <measurement group_id="B3" value="10.3" spread="4.3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Mean endothelial cell density</title>
          <units>cells/mm^2</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="1940" spread="418"/>
                    <measurement group_id="B2" value="1718" spread="449"/>
                    <measurement group_id="B3" value="1839" spread="444"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Best Corrected Visual Acuity (BCVA)</title>
        <description>Measure for visual function. Measured in logMAR</description>
        <time_frame>6 months, 1 year and 2 years</time_frame>
        <group_list>
          <group group_id="O1">
            <title>IOL Repositioning</title>
            <description>Operation method: Intraocular lens repositioning by scleral suturing</description>
          </group>
          <group group_id="O2">
            <title>IOL Exchange</title>
            <description>Operation method: Intraocular lens exchange with retropupillary iris-claw lens</description>
          </group>
        </group_list>
        <measure>
          <title>Best Corrected Visual Acuity (BCVA)</title>
          <description>Measure for visual function. Measured in logMAR</description>
          <units>logMAR</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="43"/>
                <count group_id="O2" value="42"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>BCVA 6 months</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.24" spread="0.29"/>
                    <measurement group_id="O2" value="0.35" spread="0.54"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>BCVA 1 year</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.21" spread="0.26"/>
                    <measurement group_id="O2" value="0.23" spread="0.34"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>BCVA 2 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.20" spread="0.29"/>
                    <measurement group_id="O2" value="0.22" spread="0.30"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Intraocular Pressure (IOP)</title>
        <description>Measure for the pressure inside the eye, measured with Goldman applanation tonometer, in mmHg.</description>
        <time_frame>6 months and 2 years</time_frame>
        <group_list>
          <group group_id="O1">
            <title>IOL Repositioning</title>
            <description>Operation method: Intraocular lens repositioning by scleral suturing</description>
          </group>
          <group group_id="O2">
            <title>IOL Exchange</title>
            <description>Operation method: Intraocular lens exchange with retropupillary iris-claw lens</description>
          </group>
        </group_list>
        <measure>
          <title>Intraocular Pressure (IOP)</title>
          <description>Measure for the pressure inside the eye, measured with Goldman applanation tonometer, in mmHg.</description>
          <units>mmHg</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="43"/>
                <count group_id="O2" value="42"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>IOP 6 months</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="16.5" spread="5.2"/>
                    <measurement group_id="O2" value="14.9" spread="4.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>IOP 2 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="15.7" spread="4.0"/>
                    <measurement group_id="O2" value="14.1" spread="4.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Endothelial Density</title>
        <description>Corneal endothelial cell density (ECD), measured by confocal microscopy. Reported in cells per square millimeter</description>
        <time_frame>6 months</time_frame>
        <population>Some missing data due to inadequate corneal images</population>
        <group_list>
          <group group_id="O1">
            <title>IOL Repositioning</title>
            <description>Operation method: Intraocular lens repositioning by scleral suturing</description>
          </group>
          <group group_id="O2">
            <title>IOL Exchange</title>
            <description>Operation method: Intraocular lens exchange with retropupillary iris-claw lens</description>
          </group>
        </group_list>
        <measure>
          <title>Endothelial Density</title>
          <description>Corneal endothelial cell density (ECD), measured by confocal microscopy. Reported in cells per square millimeter</description>
          <population>Some missing data due to inadequate corneal images</population>
          <units>cells/mm^2</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="37"/>
                <count group_id="O2" value="33"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1858" spread="433"/>
                    <measurement group_id="O2" value="1514" spread="470"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Postoperative Complications</title>
        <description>Cystoid macular edema considered the most important long-term complication and therefore reported here.</description>
        <time_frame>6 months and 2 years</time_frame>
        <population>Some loss to follow-up</population>
        <group_list>
          <group group_id="O1">
            <title>IOL Repositioning</title>
            <description>Operation method: Intraocular lens repositioning by scleral suturing</description>
          </group>
          <group group_id="O2">
            <title>IOL Exchange</title>
            <description>Operation method: Intraocular lens exchange with retropupillary iris-claw lens</description>
          </group>
        </group_list>
        <measure>
          <title>Postoperative Complications</title>
          <description>Cystoid macular edema considered the most important long-term complication and therefore reported here.</description>
          <population>Some loss to follow-up</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="43"/>
                <count group_id="O2" value="42"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>CME 6 months</title>
              <category_list>
                <category>
                  <title>Cystoid macular edema</title>
                  <measurement_list>
                    <measurement group_id="O1" value="3"/>
                    <measurement group_id="O2" value="4"/>
                  </measurement_list>
                </category>
                <category>
                  <title>No cystoid macular edema</title>
                  <measurement_list>
                    <measurement group_id="O1" value="40"/>
                    <measurement group_id="O2" value="38"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>CME 2 years</title>
              <category_list>
                <category>
                  <title>Cystoid macular edema</title>
                  <measurement_list>
                    <measurement group_id="O1" value="5"/>
                    <measurement group_id="O2" value="6"/>
                  </measurement_list>
                </category>
                <category>
                  <title>No cystoid macular edema</title>
                  <measurement_list>
                    <measurement group_id="O1" value="38"/>
                    <measurement group_id="O2" value="36"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Keratometry</title>
        <description>Keratometry of the cornea. Corneal astigmatism, measured in diopters.</description>
        <time_frame>6 months (only analyzed/reported for this time frame)</time_frame>
        <population>Some missing data due to poor image/measurement quality, overall number of participants therefore lower than the number of participants attending the 6-month visit</population>
        <group_list>
          <group group_id="O1">
            <title>IOL Repositioning</title>
            <description>Operation method: Intraocular lens repositioning by scleral suturing</description>
          </group>
          <group group_id="O2">
            <title>IOL Exchange</title>
            <description>Operation method: Intraocular lens exchange with retropupillary iris-claw lens</description>
          </group>
        </group_list>
        <measure>
          <title>Keratometry</title>
          <description>Keratometry of the cornea. Corneal astigmatism, measured in diopters.</description>
          <population>Some missing data due to poor image/measurement quality, overall number of participants therefore lower than the number of participants attending the 6-month visit</population>
          <units>Diopters</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="40"/>
                <count group_id="O2" value="39"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.2" spread="1.0"/>
                    <measurement group_id="O2" value="1.2" spread="0.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Questionnaire Visual Function-14 (VF-14) Score</title>
        <description>Questionnaire considering subjective visual function, scale 0-100 (higher scores mean better subjective visual outcome, lower scores means worse outcome).</description>
        <time_frame>6 months (only analyzed/reported for this time frame)</time_frame>
        <population>Some loss to follow-up</population>
        <group_list>
          <group group_id="O1">
            <title>IOL Repositioning</title>
            <description>Operation method: Intraocular lens repositioning by scleral suturing</description>
          </group>
          <group group_id="O2">
            <title>IOL Exchange</title>
            <description>Operation method: Intraocular lens exchange with retropupillary iris-claw lens</description>
          </group>
        </group_list>
        <measure>
          <title>Questionnaire Visual Function-14 (VF-14) Score</title>
          <description>Questionnaire considering subjective visual function, scale 0-100 (higher scores mean better subjective visual outcome, lower scores means worse outcome).</description>
          <population>Some loss to follow-up</population>
          <units>score points</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="43"/>
                <count group_id="O2" value="42"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="91.6" spread="16.4"/>
                    <measurement group_id="O2" value="90.1" spread="18.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>IOL Location</title>
        <description>Measure IOL's location with slit lamp and Pentacam.</description>
        <time_frame>2 years</time_frame>
        <posting_date>12/2020</posting_date>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>6 months</time_frame>
      <desc>Adverse events were registered as specific perioperative and postoperative complications related to the surgery.
Otherwise we registered the number of participants that were lost to-follow up due to serious illness (other conditions than the studied) or death.</desc>
      <group_list>
        <group group_id="E1">
          <title>IOL Repositioning</title>
          <description>Operation method: Intraocular lens repositioning by scleral suturing</description>
        </group>
        <group group_id="E2">
          <title>IOL Exchange</title>
          <description>Operation method: Intraocular lens exchange with retropupillary iris-claw lens</description>
        </group>
      </group_list>
      <serious_events>
        <default_assessment>Non-systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="54"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="50"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="10" subjects_at_risk="54"/>
                <counts group_id="E2" subjects_affected="8" subjects_at_risk="50"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>General disorders</title>
            <event_list>
              <event>
                <sub_title>Serious illness</sub_title>
                <description>Serious adverse events were not related to intervention, &quot;General disorders&quot; were therefore chosen as a common term. The study population had a high age and therefore serious illness of some participants were anticipated</description>
                <counts group_id="E1" events="10" subjects_affected="10" subjects_at_risk="54"/>
                <counts group_id="E2" events="8" subjects_affected="8" subjects_at_risk="50"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>5</frequency_threshold>
        <default_assessment>Non-systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="43"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="42"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Eye disorders</title>
            <event_list>
              <event>
                <sub_title>Cystoid macular edema</sub_title>
                <description>Postoperative complication, registered at the 6-month postoperative visit</description>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="43"/>
                <counts group_id="E2" events="4" subjects_affected="4" subjects_at_risk="42"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>All Principal Investigators ARE employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <limitations_and_caveats>Limitations to the study / the result:
Some loss to follow-up Some missing data for some of the parameters</limitations_and_caveats>
    <point_of_contact>
      <name_or_title>Dr. Olav Kristianslund</name_or_title>
      <organization>Oslo University Hospital</organization>
      <phone>+4723015168</phone>
      <email>olav.kristianslund@medisin.uio.no</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

